$KLRA news
The latest KLRA stock news: headlines, filings, AI summaries and sentiment for $KLRA, updated around the clock.
- Kailera Therapeutics Reports Third Quarter Financial Results
- Kailera Therapeutics, Inc. - 10-Q Filing
- Kailera Therapeutics, Inc. - 8-K Filing
- TG Therapeutics Initiates Phase 2 Trial for Briumvi in Treatment-Resistant Schizophrenia
- Kailera Therapeutics Reports Positive Phase 3 Trial Results for Obesity Treatment
- Kailera Reports Late-Stage Trial Data for Oral GLP-1 Drug
- Kardigan Shares Rise on Nasdaq Debut Following $400 Million IPO